Ticker League

Revenue for Bristol-Myers Squibb (BMY)

Latest filings through · Reported

Metric

TTM

$48.48B

YoY change

-0.2%

5Y CAGR

+2.5%

Peak year (2024)

$48.30B

Revenue history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025

Latest: $48.19B

Revenue growth chart for Bristol-Myers Squibb (BMY) from 1987 to 2025

Latest: -0.2%

Revenue history table for Bristol-Myers Squibb (BMY) from 1987 to 2025

  • 2025$48.19B-0.2%
  • 2024$48.30B+7.3%
  • 2023$45.01B-2.5%
  • 2022$46.16B-0.5%
  • 2021$46.38B+9.1%
  • 2020$42.52B+62.6%
  • 2019$26.14B+15.9%
  • 2018$22.56B+8.6%
  • 2017$20.78B+6.9%
  • 2016$19.43B+17.3%
  • 2015$16.56B+4.3%
  • 2014$15.88B-3.1%
  • 2013$16.39B-7.0%
  • 2012$17.62B-17.1%
  • 2011$21.24B+9.0%
  • 2010$19.48B+3.6%
  • 2009$18.81B-8.7%
  • 2008$20.60B+6.5%
  • 2007$19.35B+8.0%
  • 2006$17.91B-6.7%
  • 2005$19.21B-0.9%
  • 2004$19.38B-7.2%
  • 2003$20.89B+15.3%
  • 2002$18.12B-6.7%
  • 2001$19.42B+6.6%
  • 2000$18.22B-9.9%
  • 1999$20.22B+10.6%
  • 1998$18.28B+9.5%
  • 1997$16.70B+10.9%
  • 1996$15.06B+9.4%
  • 1995$13.77B+14.9%
  • 1994$11.98B+5.0%
  • 1993$11.41B+2.3%
  • 1992$11.16B-0.0%
  • 1991$11.16B+8.3%
  • 1990$10.30B+12.1%
  • 1989$9.19B+7.4%
  • 1988$8.56B+13.2%
  • 1987$7.56B—

Revenue values are taken from Bristol-Myers Squibb's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Revenue at Bristol-Myers Squibb (BMY)

According to Bristol-Myers Squibb's latest reported financial statements, the company's current revenue (TTM) is $48.48B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

As of the 2025 fiscal year, Bristol-Myers Squibb (BMY) reported revenue of $48.19B – edged down 0.2% year-over-year.

Through 2020–2025 (5 years), Bristol-Myers Squibb revenue delivered a +2.5% annualised rate; with mixed annual results across the window.

The highest annual revenue of $48.30B was reported in 2024. The lowest in the available history was $7.56B in 1987.

Bristol-Myers Squibb Revenue by Year

Bristol-Myers Squibb Revenue 2025: $48.19B

2025's revenue for Bristol-Myers Squibb came in at $48.19B, edged down 0.2% below 2024.

Bristol-Myers Squibb Revenue 2024: $48.30B

Bristol-Myers Squibb posted revenue of $48.30B in 2024, grew 7.3% from 2023. This figure represents the highest annual value in the available history.

Bristol-Myers Squibb Revenue 2023: $45.01B

In 2023, Bristol-Myers Squibb reported revenue of $45.01B, edged down 2.5% below 2022.

Bristol-Myers Squibb Revenue 2022: $46.16B

Bristol-Myers Squibb revenue in 2022 was $46.16B, edged down 0.5% below 2021.

Bristol-Myers Squibb Revenue 2021: $46.38B

Bristol-Myers Squibb revenue in 2021 was $46.38B.

See more financial history for Bristol-Myers Squibb (BMY).

Sector peers by Revenue

Healthcare peers of Bristol-Myers Squibb (BMY), ranked by their latest revenue

Frequently asked questions

Bristol-Myers Squibb (BMY) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview